Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only low dose acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only inactivated whole Influenza A virus subtype H5N1 antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product) |
Plays role |
False |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product against severe acute respiratory syndrome coronavirus 2 (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Human alphaherpesvirus 3 recombinant surface glycoprotein E antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Influenza A virus A/Indonesia/05/2005 (H5N1)-like virus strain split virion hemagglutinin antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Pediatric vaccine product containing only acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b conjugated, Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Neisseria meningitidis serogroup A antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F capsular polysaccharide conjugated antigens (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F capsular polysaccharide antigens conjugated (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing live attenuated virus antigen (medicinal product) |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigens (medicinal product) |
Plays role |
False |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Haemophilus type b conjugate vaccine powder and solvent for solution for injection 0.5ml vials |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Haemophilus type b conjugate vaccine solution for injection 0.5ml vials |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Generic Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|
Generic COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials |
Plays role |
True |
Active immunity stimulant role |
Inferred relationship |
Existential restriction modifier |
|